Showing results (351-360 of 610) with videos related to

Sort By:
Pageof 61
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Thrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosisD Collen, J M Stassen, M Blaber, et al.
The Journal of Biological Chemistry|August 26, 1998
NH2-terminal structural motifs in staphylokinase required for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.
The Journal of Biological Chemistry|July 3, 1999
Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 geneH Ding, A M Benotmane, G Suske, et al.
The Journal of Clinical Investigation|March 1, 1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosisC Korninger, O Matsuo, R Suy, et al.
The Journal of Biological Chemistry|February 28, 1997
Staphylokinase requires NH2-terminal proteolysis for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.
Blood|September 1, 1992
Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis modelY Imura, J M Stassen, S Bunting, et al.
Thrombosis and Haemostasis|August 20, 1986
Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteersM Verstraete, C A Su, P Tanswell, et al.
Circulation|October 15, 1996
Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodelingZ Nong, J M Stassen, L Moons, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.
Pageof 61